Business & Finance
Sontra Medical reports Q3 2006 49-cent-per-share loss, efforts to raise private capital
Published in Healthcare Mergers, Acquisitions and Ventures Week, December 23rd, 2006
For the 9 months ended September 30, 2006, the net loss applicable to common stockholders was $4,229,286, or $1.60 per common share, as compared to $4,556,259 or $2.05 per common share, for the same period in 2005. As of September 30, 2006, the company had a total of $1,677,256 in cash and short term investments.
On July 24, 2006, the company's board of directors...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- Accreditation
BlueCross BlueShield of Tennessee awarded URAC Consumer Education and Support Accreditation - Accreditation
Corphealth receives URAC Health Utilization Management Reaccreditation - Age-Related Macular Degeneration
Novartis gets positive E.U. regulatory opinion on ranibizumab treatment for vision loss - Allergic Rhinitis
China Biopharmaceuticals completes all clinical trials of Desloratadine for hay fever - Alzheimer Disease
Nymox pursuing new approaches to Alzheimer disease - Alzheimer Disease
Prana Biotechnology raises $6 million for Phase IIa clinical trial of PBT2 in Alzheimer disease - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
